Compare 8x8 Inc (EGHT) vs Koninklijke Philips NV (PHG) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
8x8 Inc vs Koninklijke Philips NV — how do they compare? 8x8 Inc trades at $2.17 (market cap $311.98M), while Koninklijke Philips NV trades at $24.57 (market cap $23.52B). The key difference: Koninklijke Philips NV is far larger — about 75.4× 8x8 Inc's market cap, and Koninklijke Philips NV pays a 4.17% dividend while 8x8 Inc pays none. Which is the better fit depends on your goals — on Pluang, investors hold 8x8 Inc for 16 Days and Koninklijke Philips NV for 84 Days on average.
| EGHT | PHG | |
|---|---|---|
Market Cap | $311.98M | $23.52B |
Volume | 1,639,086 | 1,635,069 |
Sector | Technology | Health |
52-Week High | $2.76 | $32.91 |
52-Week Low | $1.59 | $23.81 |
Typical Hold Time | 16 Days | 84 Days |
Enterprise Value | $578.90M | $29.87B |
Dividend Yield | — | 4.17% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
EGHT trades at $2.14, down 1.38% on the day. The stock exhibits a bullish technical signal with positive moving averages, while recent earnings have consistently beaten expectations. Revenue for 2025 was $715.07M, though the company reported a net loss of $27.21M. Positive news includes a 50% cost reduction for a major client using its platform and recent industry award recognition, highlighting operational strengths.
The outlook is mixed; analyst consensus is a Buy with a $19.77 price target, signaling significant upside potential. However, high debt levels and thin net margins pose risks. The projected return to profitability in 2026 is a key catalyst, but execution risks and competitive pressures in the cloud communications sector remain concerns for investors.
PHG trades at $24.09, down 0.25% with a bearish technical signal. The company shows improving fundamentals with three consecutive quarterly EPS beats and a return to profitability in 2025 (net income $895M). Recent news highlights innovation in healthcare technology including new product launches and AI partnerships. Valuation metrics appear reasonable with P/E of 18.94 and P/S of 1.18.
PHG presents a mixed outlook with strong operational recovery but technical weakness. The investment case hinges on continued earnings momentum and successful execution of healthcare technology initiatives. Key risks include competitive pressures and potential cybersecurity vulnerabilities following recent hacking incidents. Analyst consensus leans neutral with 36% buy ratings versus 64% hold.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
No sentiment data available yet.
About 8x8 Inc
8x8 is a provider of integrated cloud communications and contact center solutions. Its platform combines voice, video, chat, and contact center functionality into a single application to help businesses collaborate.
Read more on EGHT →About Koninklijke Philips NV
Philips is a diversified global healthcare company operating in three segments: diagnosis and treatment, connected care, and personal health. About 50% of the company's revenue comes from the diagnosis and treatment segment, which features imaging systems, ultrasound equipment, image-guided therapy solutions and healthcare informatics. The connected care segment (27% of revenue) encompasses monitoring and analytics systems for hospitals and sleep and respiratory care devices, whereas the personal health business (remainder of revenue) includes electric toothbrushes and men's grooming and personal-care products. In 2021, Philips generated EUR 17.2 billion in sales and had 80,000 employees in over 100 countries.
Read more on PHG →
